Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPIVACAINE Cause Malignant neoplasm progression? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Malignant neoplasm progression have been filed in association with BUPIVACAINE (Bupivacaine Hydrochloride). This represents 0.1% of all adverse event reports for BUPIVACAINE.

7
Reports of Malignant neoplasm progression with BUPIVACAINE
0.1%
of all BUPIVACAINE reports
6
Deaths
0
Hospitalizations

How Dangerous Is Malignant neoplasm progression From BUPIVACAINE?

Of the 7 reports, 6 (85.7%) resulted in death.

Is Malignant neoplasm progression Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPIVACAINE. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does BUPIVACAINE Cause?

Drug ineffective (3,068) Off label use (912) Pain (746) Anaesthetic complication (585) Maternal exposure during pregnancy (491) Hypotension (460) Hypoaesthesia (455) Exposure during pregnancy (391) Nausea (328) Drug withdrawal syndrome (280)

What Other Drugs Cause Malignant neoplasm progression?

PEMBROLIZUMAB (10,111) NIVOLUMAB (9,363) ENZALUTAMIDE (4,696) CARBOPLATIN (4,177) EVEROLIMUS (3,789) PACLITAXEL (3,484) LETROZOLE (3,445) IPILIMUMAB (3,296) FULVESTRANT (3,221) LENVATINIB (2,929)

Which BUPIVACAINE Alternatives Have Lower Malignant neoplasm progression Risk?

BUPIVACAINE vs BUPIVACAINE\BUPIVACAINE ANHYDROUS BUPIVACAINE vs BUPIVACAINE\EPINEPHRINE BUPIVACAINE vs BUPIVACAINE\MELOXICAM BUPIVACAINE vs BUPRENORPHINE BUPIVACAINE vs BUPRENORPHINE\NALOXONE

Related Pages

BUPIVACAINE Full Profile All Malignant neoplasm progression Reports All Drugs Causing Malignant neoplasm progression BUPIVACAINE Demographics